BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240627T090000
DTEND;TZID=Europe/Vienna:20240628T170000
DTSTAMP:20260422T120925
CREATED:20240213T181456Z
LAST-MODIFIED:20240627T125940Z
UID:1238-1719478800-1719594000@esmit.eanm.org
SUMMARY:Role of FDG-PET in Paediatric Hodgkin and Non-Hodgkin Lymphomas
DESCRIPTION:UEMS EACCME has granted the accreditation of 8 CME credits for this event. \n\n\n\nA large oncological framework will be the topic of the first session: three lectures by a high quoted Paediatric Oncologist: epidemiology\, aetiological factors\, and general classification of Paediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies and prognostic considerations. The two valuable nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas: staging and therapeutic management\, the importance of the imaging-based assessment\, the role of Deauville classification\, prognostic aspects\, surveillance\, and the management of recurrent/treatment resistant forms in PHL and NHL. Current state of experimental tracers research. Future perspectives: novel radiotracers\, evaluation of rare entities and advanced image analysis.  \n\n\n\nMany case readings will be presented to the attendees to train them in interpreting and concluding 18FDG in the crucial assessment point into diagnostic- therapeutic PHL and NHL protocols. \n\n\n\nEach attendee is also asked to present a personal tricky case\, proposed to the experts and to the other attendees. This allows better communication among the attendees and a more interactive practical session. \n\n\n\n\n\n\n\nSave yourself a seatThe registration is closed. For last minute interest\, contact esmit@eanm.org  Register now!\n\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\nResidents\, NM specialist approaching paediatric ematology-oncology\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nThe aim of this course is initially to refresh and update clinical setting from the point of view of the pediatric Oncologist: epidemiology\, aetiological factors\, and general classification of Pediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies. \n\n\n\nThe two nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas and about the importance of imaging-based assessment\, and the role of Deauville classification in the main forms of PHL and NHL.  \n\n\n\nThe current state of experimental tracers research and future perspectives: novel radiotracers\, evaluation of rare entities and advanced image analysis. Two interactive sessions with a lot of case reading to train the attendees in the evaluation\, interpretation and comparison of 18FDG-PET-CT.  \n\n\n\n\n\n\n\n\n\nProgrammeClick to view the preliminary programme View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nMarta PillonSpeakerItaly \n\n\n\n\n\nPinar KiratliSpeakerTürkiye \n\n\n\n\n\nFrancesco FizSpeakerItaly \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee Breaks on each Course Day\n\n\n\nLunch on first Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/role-of-fdg-pet-in-paediatric-hodgkin-and-non-hodgkin-lymphomas/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
END:VCALENDAR